SEC Comment Letter for SEABRIGHT INSURANCE HOLDINGS INC (CIK 0001267201) — Oct 19, 2004
SEABRIGHT INSURANCE HOLDINGS INC (CIK 0001267201)
Date: Oct. 19, 2004 · CIK: 0001267201 · Accession: 0000000000-04-033456
AI Filing Summary & Sentiment
File numbers found in text: 333-119111
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> Mail Stop 3-09 October 15, 2004 John G. Pasqualetto Chairman, President, and Chief Executive Officer SeaBright Insurance Holdings, Inc. 2101 4th Avenue, Suite 1600 Seattle, WA 98121 Re: SeaBright Insurance Holdings, Inc. Registration Statement on Form S-1 File Number 333-119111 Dear Mr. Pasqualetto: We have reviewed your filing and have the following comments. Where indicated, we think you should revise your document in response to these comments. If you disagree, we will consider your explanation as to why our comment is inapplicable or a revision is unnecessary. Please be as detailed as necessary in your explanation. In some of our comments, we may ask you to provide us with supplemental information so we may better understand your disclosure. After reviewing this information, we may or may not raise additional comments. Please understand that the purpose of our review process is to assist you in your compliance with the applicable disclosure requirements and to enhance the overall disclosure in your filing. We look forward to working with you in these respects. We welcome any questions you may have about our comments or on any other aspect of our review. Feel free to call us at the telephone numbers listed at the end of this letter. FORM S-1 General 1. Please provide us proofs of all graphic, visual, or photographic information you will provide in the printed prospectus prior to its use, for example in a preliminary prospectus. Please note we may have comments regarding these materials. 2. Please complete all of the non-pricing blank sections of your filing prior to filing the next amendment. 3. Please note that when you file a pre-effective amendment containing pricing-related information, we may have additional comments. As you are likely aware, you must file this amendment prior to circulating the prospectus. 4. Please note that when you file a pre-effective amendment that includes your price range, it must be bona fide. We interpret this to mean that your range may not exceed $2 if you price below $20 and 10% if you price above $20. 5. Please note that where we provide examples to illustrate what we mean by our comments, they are examples and not complete lists. If our comments are applicable to portions of the filing that we have not cited as examples, please make the appropriate changes in accordance with our comments. Table of Contents 6. You should retain only the Table of Contents on this page. All other information should be disclosed after the Risk Factors section. Note On Forward-Looking Statements 7. Please relocate the section entitled "Note on Forward-Looking Statements" so that it appears after the risk factors section. 8. Please delete the statement that "[a]ll subsequent written and oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by this paragraph." This statement may appear to be a disclaimer of responsibility for the statements contained in your filing. It should be sufficient to state that actual results could differ materially from the forward-looking statements Prospectus Summary, page 1 9. Please provide us with a marked copy of the A.M. Best Company report supporting your statement regarding your subsidiary, SeaBright Insurance Company. 10. Please eliminate jargon and technical terms from the prospectus and provide a "Plain English" explanation or substitute. For example, these words and phrases appear in your summary or risk factors sections: * "claim severity" * "severity trend" * "commutation agreement" * "ceded reinsurance" * "dislocation" * "run off plan" 11. The company should not rely upon a glossary of defined terms. Please eliminate the glossary key by substituting non-technical terms for defined terms to the extent you can throughout the prospectus or explaining these terms in plain English the first time they appear in the prospectus. Please refer to Item 421 of Regulation C. 12. Does the company have actual or pending patents or trademarks for its proprietary analytical tools? If so, this information should be disclosed. If not, please clarify or use a substitute for the word proprietary. (page 3) 13. Please clarify how you calculated the $8.4 billion in net premiums, as the potential market size for the company. Although you have broken out this figure by the type of market, how did you calculate this amount? Cite any sources you relied upon, and provide us with marked copies of these sources. (page 4) 14. Under "The Acquisition" please briefly expand the disclosure to state not only what you received when you did the buyout and the acquisition of KEIC but also disclose the cost of the buyout including the acquisition of KEIC . The disclosure should include all forms of consideration including the type and amount of equity and debt issued by the company. (page 5) 15. Under "Corporate Structure" please briefly describe the business of the two subsidiaries. (page 6) Risk Factors General, page 10 16. Please refer to your statement in the introductory paragraph under "Risk Factors" please delete the third sentence beginning with "[a]dditional risks not presently known to us." You must disclose all risks that you believe are material at this time. 17. Please revise the risk factors where appropriate to replace generic language with specific disclosure of exactly how these risks have affected and will affect your operations, financial condition or business, and if practicable to quantify, the specific and immediate effects to investors of each risk that you have identified. For example, you use general phrases such as "materially adversely affected" throughout the risk factor section. These generic phrases are subject to varying interpretations and, therefore, do not adequately explain the risk or concern to which you refer. Our geographic concentration ties our performance to the business ..., page 10 18. Please revise to describe how unfavorable business, economic or regulatory conditions have impacted your business in the past. To the extent practicable, please quantify. For example, claims resulting from tsunamis, earthquakes or hurricanes. If we are unable to obtain or collect on ceded reinsurance ..., page 10 19. Please disclose what percentage of your business you reinsure. If 100% of your policies are reinsured, so state. 20. Please disclose problems the company has experienced from the failure of a reinsurer to pay in full and in a timely manner any material claims the company has presented to them, if applicable. Additionally, please disclose the nature of any current difficulties you are experiencing regarding the enforcement of your rights to receive payment under reinsurance agreements. 21. Please expand to discuss what the company would do in the event that a reinsurer cancels its participation on new business. For example, approximately how many companies could provide you with reinsurance services in the volume you require? Disclose the difficulties you would likely encounter in finding and negotiating an agreement for reinsurance from another source. 22. If an inability to qualify for reinsurance has adversely affected your business in the past, please discuss the specific situation. The insurance business is subject to extensive regulation ..., page 11 23. To the extent any of the types of regulations identified in the bullet points has materially affected your business in the past, please discuss the situation and its consequences. Also, please identify and discuss the material risks presented by the other regulations you identified. For example, California`s workers` compensation legislation. A downgrade in the A.M. Best rating of our insurance ..., page 12 24. Please discuss if the company has received any communications from A.M. Best related to whether your insurance subsidiary may be downgraded or on a credit watch for possible downgrading. Intense competition could adversely affect our ability to sell ..., page 12 25. To the extent known or easily obtainable, please identify your principal competitors` share of the market. We could be adversely affected by the loss of one or more ..., page 13 26. To the extent that you have experienced difficulties attracting and retaining key personnel, please revise to discuss these difficulties. We rely on independent insurance brokers ..., page 14 27. To the extent the company has experienced difficulties in recruiting or hiring qualified independent insurance brokers, revise to discuss these difficulties. 28. Please also explain that the agents may promote products offered by companies that offer a larger variety of products. In the event LMC is placed into receivership ..., page 15 29. Please include a brief discussion of LMC under "Our Challenges" in the Prospectus Summary. Additionally, please include a discussion of this factor in the MD&A section as an uncertainty that could affect future results. 30. Please revise this risk factor in its entirety. As is currently written, this risk factor is convoluted and difficult to read, particularly, bullet points 3 and 4. Additionally, please clearly define LMC and its relation with the company. Also, please describe what is collateralized in the collateralized reinsurance trust. Our results of operations and revenues may fluctuate ..., page 16 31. Please revise to describe the current phase in the cycle and how it is affecting your operations and profitability. Compare current conditions with conditions previously. If you believe your profitability has in the past been adversely affected by negative developments and cyclical changes in the industry, please provide appropriate disclosure. Future sales of shares of our common stock my affect ..., page 17 32. Please state how many shares are subject to the 180-day lock-up agreements. Public investors will suffer immediate and substantial dilution ..., page 18 33. Please revise this risk factor to explain that investors who purchase shares will: * Pay a price per share that substantially exceeds the value of your assets after subtracting its liabilities; and * Contribute ___% of the total amount to fund the company but will own only ___% of the shares outstanding. The Acquisition, page 20 34. Please revise the text under "Arrangements to Minimize Exposure" using plain English to clearly and concisely explain the agreements. Although, included as exhibits to the prospectus, please clearly explain the material terms of these agreements and what potential liability exists to the company. 35. Please include a discussion of what types of products and services KEIC and LMC offered prior to the MBO and what the 2 entities do currently. 36. Please disclose the amount of fee income the company receives from its services agreements with LMC and its affiliates under "Services Arrangements." Use of Proceeds, page 22 37. Please specify which general corporate purposes the proceeds you do not contribute to your insurance company subsidiary will be used for. 38. Please provide the approximate dollar amount that you plan to contribute to your insurance company subsidiary, as well as the amount to be used for any other purposes you identify pursuant to the previous comment. Dilution, page 23 39. Please disclose your historical net tangible book value per share before conversion of the convertible preferred stock. Please revise to present line items for historical tangible book value per share and the amounts attributable to pro forma adjustments, such as conversion of convertible preferred stock, to arrive at a pro forma tangible book value per share. Unaudited Pro Forma Financial Information, pages 25-27 40. Please revise the head note to the pro forma statement of operations as follows: * Provide a more specific discussion of how the investor should utilize the pro forma financial information. We note your conflicting statements that it is for comparative purposes but does not represent what operations would have been had the Acquisition occurred on January 1, 2003. Please clarify these statements to be more consistent with the objective of Article 11, which is to provide investors with information about the continuing impact of a transaction by showing how it might have affected the historical financial statements; * Describe the specific activities relating to the policies written prior to January 1, 2003 that have been retained in the pro forma presentation and those that have been eliminated from this presentation. It appears that much of the activity in the pre Acquisition renewal process should be presented in the pro forma financial information; and * Clarify your disclosures to state that the pro forma statement of operations excludes the operations of SBIC prior to September 30, 2003. 41. Pro forma footnote disclosures should be sufficiently detailed to understand your basis for the adjustment and how the adjustment was computed. For example, please expand your description of pro forma adjustments "a", "c", "g", "h" and "i" so that investors can better understand the related objectives, calculation methods and assumptions and historical information utilized. Tell us how these adjustments are factually supportable and create a better representation of the continuing impact of the Acquisition than actual 2003 revenues and expenses for predecessor and the company. 42. Please revise your disclosures in pro forma adjustments "e" and "k" to clarify that the tax effects of any pro forma adjustments are calculated at the "statutory" rate in effect during the periods presented. Please refer to Instruction 7 to Rule 11-02 of Regulation S-X. 43. We note that pro forma net premiums earned and pro forma net income are significantly greater than the corresponding actual amounts for prior years and for the six months ended June 30, 2004. In particular, pro forma net income for 2003 is 3.6 times net income for the six months ended June 30, 2004. Please explain the implications of this relationship so that investors can better understand the continuing impact of the Acquisition. 44. It appears that the terms of prior predecessor reinsurance program differs from the terms of the company`s current reinsurance program. Please explain how you considered these differences in preparing the pro forma financial information. 45. You disclose that the quota share reinsurance agreements between EPIC, PEIC and LMC stipulated 20% retention. However, the amounts reflected in pro forma adjustments "a" and "c" appear to indicate 10% retention. Please explain this apparent inconsistency. Also, explain why adjustments "g", "h" and "i" do not appear to include any impact from reinsurance. 46. Please remove all historical and pro forma "Other Data" since this information is not contemplated in the preparation requirements of Article 11 of Regulation S-X. Please revise your disclosures in other sections of the filings, accordingly. Management`s Discussion and Analysis of Financial Condition and Results of Operations Overview, page 30 47. Please expand your disclosures, and explain to us, how the loss ratio and expense ratio of your business is comparable with the business of the predecessor. Results of Operations Six Months Ended June 30, 2004 Compared to Six Months Ended June 30, 2003, page 38 48. Please explain in greater detail the basis for your decision to substitute a comparison of trends and ratios for the six months ended June 30, 2004 to the three months ended December 31, 2003 for a comparison of trends and ratios for the six months ended June 30, 2004 to the six months ended June 30, 2003. 49. Please include a discussion of the company`s actual experience in exercising the acquired renewal rights during the six months ended June 30, 2004. 50. Please expand